Hsbc Holdings PLC acquired a new stake in shares of Ventas, Inc. (NYSE:VTR – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 2,139,057 shares of the real estate investment trust’s stock, valued at approximately $190,099,000.
A number of other hedge funds have also made changes to their positions in VTR. Dynamic Wealth Strategies LLC bought a new stake in Ventas during the first quarter worth approximately $25,000. Wiser Advisor Group LLC bought a new position in shares of Ventas in the third quarter valued at approximately $27,000. Silvant Capital Management LLC bought a new position in shares of Ventas in the second quarter valued at approximately $28,000. Meeder Asset Management Inc. bought a new position in shares of Ventas in the second quarter valued at approximately $30,000. Finally, IFC & Insurance Marketing Inc. acquired a new stake in shares of Ventas in the fourth quarter worth $30,000. Institutional investors and hedge funds own 94.18% of the company’s stock.
Insiders Place Their Bets
In other Ventas news, Director Michael J. Embler bought 2,500 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The shares were acquired at an average price of $78.81 per share, with a total value of $197,025.00. Following the completion of the purchase, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. The trade was a 14.97% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.53% of the stock is currently owned by insiders.
Analyst Ratings Changes
View Our Latest Stock Report on Ventas
Ventas Stock Up 0.4%
VTR opened at $93.84 on Wednesday. Ventas, Inc. has a fifty-two week low of $66.38 and a fifty-two week high of $101.60. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. The firm’s fifty day moving average price is $91.76 and its two-hundred day moving average price is $87.38. The company has a market capitalization of $48.14 billion, a P/E ratio of 173.79, a P/E/G ratio of 2.16 and a beta of 0.69.
Ventas (NYSE:VTR – Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The company had revenue of $1.73 billion during the quarter, compared to analysts’ expectations of $1.68 billion. During the same quarter in the prior year, the company posted $0.87 EPS. The business’s revenue was up 21.7% on a year-over-year basis. On average, analysts anticipate that Ventas, Inc. will post 3.89 EPS for the current year.
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
See Also
- Five stocks we like better than Ventas
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
